Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruofan Shi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Lancet Regional Health. Western Pacific|September 29, 2025
Cost-effectiveness analysis of prostate-specific antigen screening in China: a middle-income population-based microsimulation studyJiacheng Liu, Yuanshi Jiao, Yueting Huang, et al.
BMC Medicine|October 22, 2025
Profile of biological aging in first primary cancers: a pan-cancer analysis of two large-scale cohorts from the UK and Hong KongYongle Zhan, Ruofan Shi, Xiaohao Ruan, et al.
International Journal of Surgery (London, England)|February 23, 2026
Genetic risk and biomarker-derived cluster for urolithiasis risk prediction: a prospective cross-cohort study in the United Kingdom and Hong KongYongle Zhan, Ruochen Ma, Ruofan Shi, et al.
Cancer Medicine|August 9, 2024
phi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese populationRuofan Shi, Da Huang, Jiaqi Yan, et al.
JMIR Research Protocols|August 26, 2025
Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled TrialYongle Zhan, Xiaohao Ruan, Yishuo Wu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Lancet Regional Health. Western Pacific|September 29, 2025
Cost-effectiveness analysis of prostate-specific antigen screening in China: a middle-income population-based microsimulation studyJiacheng Liu, Yuanshi Jiao, Yueting Huang, et al.
BMC Medicine|October 22, 2025
Profile of biological aging in first primary cancers: a pan-cancer analysis of two large-scale cohorts from the UK and Hong KongYongle Zhan, Ruofan Shi, Xiaohao Ruan, et al.
International Journal of Surgery (London, England)|February 23, 2026
Genetic risk and biomarker-derived cluster for urolithiasis risk prediction: a prospective cross-cohort study in the United Kingdom and Hong KongYongle Zhan, Ruochen Ma, Ruofan Shi, et al.
Cancer Medicine|August 9, 2024
phi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese populationRuofan Shi, Da Huang, Jiaqi Yan, et al.
JMIR Research Protocols|August 26, 2025
Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled TrialYongle Zhan, Xiaohao Ruan, Yishuo Wu, et al.
Pageof 2